Vector Space Biosciences, Inc. PriceSBIOInactive

What is Vector Space Biosciences, Inc. (SBIO)?

Vector Space Biosciences, Inc. (SBIO) is an ERC20 utility token built on the Ethereum network that connects holders to a biotechnology and aerospace research initiative. The project combines biology, artificial intelligence modeling, and engineering to conduct scientific research in space. Using CubeSat technology, the company designs and launches biological CubeSats to generate data related to human aging, cancer, and nutrigenomics. SBIO is the second token issued by the company, following VXV, and serves as the parent company token for Vectorspace AI (VAIX). The project launched on June 30, 2021, and operates three core laboratories: a Biosciences Lab, a Hardware and CubeSat Lab, and an AI Lab. The total supply of SBIO is capped at 100,000,000 tokens, with the project self-reporting a circulating supply of 10,000,000 tokens, though this figure has not been verified by third-party data providers.

Key Specifications & Tokenomics

• Name: Vector Space Biosciences, Inc.
• Symbol / Ticker: SBIO
• Blockchain / Network: Ethereum (ETH)
• Token Standard: ERC20
• Smart Contract Address: 0x9b5C38cC2d1bA05Ed87C8f8A2418475bAcb20073
• Decimal Places: 18
• Launch Date: 2021-06-30
• Total Supply: 100,000,000 SBIO
• Max Supply: 100,000,000 SBIO
• Self-Reported Circulating Supply: 10,000,000 SBIO (10%)
• Category: Hardware, AI & Big Data, Data Provenance, Healthcare
• Explorer: etherscan.io
• Official Website: https://vectorspacebio.science/

Who created Vector Space Biosciences, Inc. (SBIO)?

Vector Space Biosciences, Inc. is led by CEO and Co-Founder Kasian Franks, who has represented the project in interviews on Nasdaq MarketSite Studio and NewtoTheStreetTV. The company has expanded its Scientific Advisory Board and collaborations, announcing three additions on November 29, 2021. One named addition is Dr. Slowey, Founder and Owner of Oasis Diagnostics Corporation and its subsidiary company Bamburgh Marrsh LLC, which was founded in 2002. A diverse team sits at the core of Vector Space Biosciences, supporting the company's research and development efforts across biotechnology, AI, and aerospace engineering.

How does Vector Space Biosciences, Inc. (SBIO) work?

The project operates through three integrated laboratories. The Biosciences Lab works in collaboration with the Scientific Advisory Board to conduct research in human aging, cancer, and nutrigenomics. The Hardware and CubeSat Lab designs and launches biological CubeSats capable of generating scientific data in space. The AI Lab develops biological language modeling, generative AI, protein sequence matching, vector databases, and advanced visualizations. This pipeline enables the development of countermeasures against diseases associated with stressors from human spaceflight, which also serve as new forms of precision medicine. SBIO operates as an ERC20 token on Ethereum, granting holders access to real-time data and images from biological CubeSat launches. The project filed for licensing and registration for the design, development, and launching of biological CubeSats on August 17, 2023. SBIO is also in the process of becoming a registered security with the SEC and will represent equity in Vector Space Biosciences.

What makes Vector Space Biosciences, Inc. (SBIO) unique and valuable?

Vector Space Biosciences occupies a distinct niche by merging space-based biological research with artificial intelligence and blockchain technology. The company's use of biological CubeSats to generate data on human aging, cancer, and nutrigenomics represents an innovative approach to precision medicine. The project has been recognized by CIO Applications Magazine as the exclusive recipient of its "Top 20 Artificial Intelligence Solutions Companies" award. Its scientific collaborations with leading laboratories in aging, cancer, and nutrigenomics research, along with an expanded Scientific Advisory Board, provide credible research backing. The dual utility of the token, offering both data access and potential equity representation through SEC registration, creates a structure that bridges traditional equity and digital assets. Additionally, the project's partnership with Advacam, formalized through a Letter of Intent signed on October 31, 2024, to develop AI models and CubeSat payloads for the space industry, further strengthens its technological foundation.

What is Vector Space Biosciences, Inc. (SBIO) used for?

SBIO tokens grant holders access to real-time data and images generated from biological CubeSat launches. According to the project's own description, the token can be used for showing ownership in the company and receiving various benefits. The token serves as a digital asset that connects its holders to the company's scientific research pipeline, including data related to human aging, cancer, and nutrigenomics. As the project progresses toward SEC registration, SBIO is positioned to represent equity in Vector Space Biosciences, offering holders a potential stake in the company's growth. The token also functions within the broader ecosystem of Vectorspace AI (VAIX), as SBIO is the parent company token following the earlier VXV token.

How Is the Vector Space Biosciences, Inc. (SBIO) ecosystem developing?

The SBIO ecosystem is expanding through scientific partnerships, educational initiatives, and market accessibility. On October 31, 2024, Advacam and Vector Space Biosciences signed a Letter of Intent to develop AI models and CubeSat payloads for the space industry, with the company's first launch scheduled for Q1/Q2 2025. On October 21, 2025, the project opened student access to its program, fostering educational engagement. The company continues to work with leading scientific labs in human aging, cancer, and nutrigenomics. SBIO became available for trading on LBank Exchange on September 24, 2023. The project's stated forward plans include further exchange listings, eventual benefits for large holders, expanding awareness, and listing on CoinGecko. Continued filing for licensing and registration for the design, development, and launching of biological CubeSats remains an ongoing priority.

How to mine Vector Space Biosciences, Inc. (SBIO)?

SBIO is an ERC20 token on the Ethereum network and is not mined through proof-of-work or proof-of-stake mechanisms. There is no mining process associated with this token. Holders can acquire SBIO through supported trading venues or decentralized exchanges where the token is available. The token functions as a utility and access asset rather than a mined cryptocurrency. Those interested in obtaining SBIO should use compatible Ethereum wallets and interact with available markets. As with any digital asset, users should verify contract addresses and ensure they are interacting with the legitimate token before conducting transactions.

How to keep your Vector Space Biosciences, Inc. (SBIO) Coin safe?

Since SBIO is an ERC20 token on Ethereum, it can be stored in any wallet that supports the ERC20 standard, including hardware wallets, software wallets, and browser-based wallets. Always verify the official contract address before interacting with the token to avoid counterfeit versions. Phantom has flagged SBIO as an unverified token, advising users to only interact with tokens they trust. Store your private keys securely and never share them with anyone. Consider using a hardware wallet for long-term holdings to minimize exposure to online threats. Be cautious of phishing attempts and fake websites claiming to represent the project. Before trading, confirm that the platform you are using lists the legitimate SBIO contract address. Given the price data discrepancies observed across various sources, exercise additional caution and conduct thorough research before making any transactions.